MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$17,479
Net Income
-$2,269,815
Net Profit Margin
-12985.95%
EPS
-$0.01
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2024-06-30
Revenues
17,479
Cost of goods sold
1,744
[gross profit]
15,735
Depreciation and amortization
108,129
Selling, general and administrative
472,984
Research and development expenses
4,063
[operating expenses]
585,176
[operating income (loss)]
-569,441
[other nonoperating income (expense)]
1,700,374
[income (loss) from continuing operations before income taxes, noncontrolling interest]
-2,269,815
Net loss
-2,269,815
Net loss
-2,269,815
[net loss]
-2,269,815
Basic EPS
-0.01
Diluted EPS
-0.01
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
AXIM Income Statement Sankey Diagram
Sankey diagram visualizing AXIM income statement for the period
[net loss]
-$2,269,815
Net loss
-$2,269,815
Net loss
-$2,269,815
[income (loss) from
continuing operations...
-$2,269,815
[other nonoperating
income (expense)]
$1,700,374
Revenues
$17,479
something is missing
-$3,400,748
[operating income (loss)]
-$569,441
[gross profit]
$15,735
Cost of goods sold
$1,744
[operating expenses]
$585,176
Selling, general and
administrative
$472,984
Depreciation and
amortization
$108,129
Research and development
expenses
$4,063
Buy us a coffee
AXIM BIOTECHNOLOGIES, INC. (AXIM)
AXIM BIOTECHNOLOGIES, INC. (AXIM)